NCT04115150 is a clinical trial in Short-term Outcome After Ventral Hernia Repair, sponsored by Medical University of Vienna.

Who is sponsoring NCT04115150?

NCT04115150 is sponsored by Medical University of Vienna.

What condition does NCT04115150 study?

NCT04115150 studies Short-term Outcome After Ventral Hernia Repair.

Is NCT04115150 still recruiting?

NCT04115150 is currently completed. Last updated 7 October 2019.

Last reviewed 2019-10-07 · How we verify

NCT04115150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-term Outcome After Ventral Hernia Repair

Completed Last updated 7 October 2019

What this trial tests

trial in Short-term Outcome After Ventral Hernia Repair in 244 participants. Completed in 1 September 2018.

Timeline

1 January 2011

Primary endpoint
1 July 2018

1 September 2018

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	244
Start date	1 January 2011
Primary completion	1 July 2018
Estimated completion	1 September 2018

Conditions studied

Short-term Outcome After Ventral Hernia Repair — all drugs for Short-term Outcome After Ventral Hernia Repair →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 99, any sex, with Short-term Outcome After Ventral Hernia Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hernia repair in sublay technique is widely accepted for ventral hernias, as it appears to be advantageous in terms of complication and recurrence rates. Recently, self-gripping meshes are increasingly used for hernia repair with retromuscular mesh positioning. However, real-life data on the safe use in that specific indication are still lacking. Therefore, this study evaluated short-term postoperative outcome of self-gripping versus conventional non-self-gripping meshes in sublay hernia repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04115150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 7 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04115150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing